CN106800601A - 一种嵌合抗原受体及其应用 - Google Patents
一种嵌合抗原受体及其应用 Download PDFInfo
- Publication number
- CN106800601A CN106800601A CN201710038685.2A CN201710038685A CN106800601A CN 106800601 A CN106800601 A CN 106800601A CN 201710038685 A CN201710038685 A CN 201710038685A CN 106800601 A CN106800601 A CN 106800601A
- Authority
- CN
- China
- Prior art keywords
- cells
- car
- chimeric antigen
- antigen receptor
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
试剂 | 剂量 |
pWPXLd-CAR-eGFP质粒 | 4.5μg |
pMD2.G辅助质粒 | 1.5μg |
psPAX2 | 6μg |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710038685.2A CN106800601B (zh) | 2017-01-19 | 2017-01-19 | 一种嵌合抗原受体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710038685.2A CN106800601B (zh) | 2017-01-19 | 2017-01-19 | 一种嵌合抗原受体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106800601A true CN106800601A (zh) | 2017-06-06 |
CN106800601B CN106800601B (zh) | 2021-04-06 |
Family
ID=58986820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710038685.2A Active CN106800601B (zh) | 2017-01-19 | 2017-01-19 | 一种嵌合抗原受体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106800601B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109971837A (zh) * | 2017-12-28 | 2019-07-05 | 上海细胞治疗研究院 | 一种外源抗体基因拷贝数的检测方法和试剂盒 |
CN111253487A (zh) * | 2018-12-03 | 2020-06-09 | 广东东阳光药业有限公司 | Cd19抗体及其应用 |
CN111848819A (zh) * | 2020-07-31 | 2020-10-30 | 广东昭泰体内生物医药科技有限公司 | 一种靶向msln的嵌合抗原受体及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014099671A1 (en) * | 2012-12-20 | 2014-06-26 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
WO2015157391A1 (en) * | 2014-04-10 | 2015-10-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Method and compositions for cellular immunotherapy |
CN106117366A (zh) * | 2016-06-24 | 2016-11-16 | 安徽未名细胞治疗有限公司 | 一种cd19特异性嵌合抗原受体及其编码基因、应用 |
CN106220736A (zh) * | 2016-07-20 | 2016-12-14 | 深圳市体内生物医药科技有限公司 | 一种嵌合抗原受体、表达其的细胞及其制备方法和用途 |
-
2017
- 2017-01-19 CN CN201710038685.2A patent/CN106800601B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014099671A1 (en) * | 2012-12-20 | 2014-06-26 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
WO2015157391A1 (en) * | 2014-04-10 | 2015-10-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Method and compositions for cellular immunotherapy |
CN106117366A (zh) * | 2016-06-24 | 2016-11-16 | 安徽未名细胞治疗有限公司 | 一种cd19特异性嵌合抗原受体及其编码基因、应用 |
CN106220736A (zh) * | 2016-07-20 | 2016-12-14 | 深圳市体内生物医药科技有限公司 | 一种嵌合抗原受体、表达其的细胞及其制备方法和用途 |
Non-Patent Citations (2)
Title |
---|
SCOTT WILKIE ET AL.: ""Retargeting of Human T Cells to Tumor-Associated MUC1:The Evolution of a Chimeric Antigen Receptor"", 《THE JOURNAL OF IMMUNOLOGY》 * |
闫小敏 等: "嵌合抗原受体修饰T细胞治疗肿瘤的最新进展", 《医学综述》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109971837A (zh) * | 2017-12-28 | 2019-07-05 | 上海细胞治疗研究院 | 一种外源抗体基因拷贝数的检测方法和试剂盒 |
CN111253487A (zh) * | 2018-12-03 | 2020-06-09 | 广东东阳光药业有限公司 | Cd19抗体及其应用 |
WO2020114358A1 (zh) * | 2018-12-03 | 2020-06-11 | 广东东阳光药业有限公司 | Cd19抗体及其应用 |
CN111253487B (zh) * | 2018-12-03 | 2024-02-02 | 广东东阳光药业股份有限公司 | Cd19抗体及其应用 |
CN111848819A (zh) * | 2020-07-31 | 2020-10-30 | 广东昭泰体内生物医药科技有限公司 | 一种靶向msln的嵌合抗原受体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106800601B (zh) | 2021-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2764471T3 (es) | Receptores de antígeno quimérico y procedimientos de fabricación | |
JP2022040287A (ja) | 養子細胞療法薬を製造するための改善された方法 | |
AU2022200257A1 (en) | Chimeric antigen receptors and methods of use thereof | |
CN107921130A (zh) | 能够结合b7‑h3和cd3的双特异性单价双抗体及其用途 | |
US20190071501A1 (en) | Anti-human pd-1 humanized monoclonal antibody and application thereof | |
JP2018509151A (ja) | トランスポザーゼポリペプチド及びその使用 | |
CN106800601A (zh) | 一种嵌合抗原受体及其应用 | |
CN109593721A (zh) | 具有自杀基因开关的靶向人间皮素的工程化免疫细胞 | |
Kwakkenbos et al. | Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire | |
CN109385400A (zh) | 共表达pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 | |
KR20210135475A (ko) | 키메라 항원 수용체 팩토리 및 이의 사용 방법 | |
CN109971722B (zh) | 靶向cd19且高水平稳定表达cd40抗体的car-t细胞及其用途 | |
CN108949828A (zh) | 表达TGF-β抗体的慢病毒载体、CAR-T细胞的构建方法及应用 | |
CN105949323A (zh) | 一种EpCAM特异性嵌合抗原受体及其编码基因、应用 | |
KR20200044711A (ko) | 항-l1cam 항체 또는 그의 항원결합 단편, 및 이를 포함하는 키메라 항원 수용체 | |
CN106978442B (zh) | 一种嵌合抗原受体t细胞的制备方法 | |
CN112313251B (zh) | 结合前列腺特异性膜抗原的嵌合抗原受体 | |
CN102827282B (zh) | 人源抗Trop-2基因工程抗体IgG及其应用 | |
EP4019538A1 (en) | Reprogramming immune cells by targeted integration of zeta-deficient chimeric antigen receptor transgenes | |
KR20200039783A (ko) | Cxcr5에 결합하는 키메라 항원 수용체 및 car-t 세포 | |
EP3946435B1 (en) | Enhancement of cytolytic t-cell activity by inhibiting ebag9 | |
CN114316060B (zh) | 抗人cd19与cd206双特异性抗体及其制备方法和应用 | |
CN114591988B (zh) | 一种激活肿瘤免疫的基因修饰干细胞制备方法 | |
CN112778417B (zh) | 一种分离的结合抗原bcma的蛋白及其用途 | |
CN111097043B (zh) | 一种胃癌药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171113 Address after: Moon Road, Science City high tech Industrial Development Zone of Guangzhou City, Guangdong province 510663 No. 80 Guangzhou science and technology innovation base in D District fifth floor Applicant after: Guangdong Zhao in vivo biological medicine technology Co., Ltd. Applicant after: Hunan Chao Yong Ren Medical Innovation Co., Ltd. Address before: 510000 Guangdong city of Guangzhou province Guangzhou City Development Zone Science and technology innovation base on Road No. 80 D District fifth floor Applicant before: Guangdong Zhao in vivo biological medicine technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
CB03 | Change of inventor or designer information |
Inventor after: Request for anonymity Inventor before: Request for anonymity |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220324 Address after: 528300 one of 0501, No. 3, Zhicheng Road, fengsha village, Daliang street, Shunde District, Foshan City, Guangdong Province Patentee after: Guangdong Zhaotai Cell Biotechnology Co.,Ltd. Address before: 510663 5th floor, Zone D, Guangzhou Science and technology innovation base, No.80, Science City, Langyue Road, Guangzhou high tech Industrial Development Zone, Guangdong Province Patentee before: GUANGDONG ZHAOTAI INVIVO BIOMEDICINE Co.,Ltd. Patentee before: Hunan Zhaotai Yongren Medical Innovation Co., Ltd |
|
TR01 | Transfer of patent right |